These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 99940)

  • 21. Elective, semielective and emergency splenorenal shunt in the treatment of bleeding esophageal varices.
    Lernau O; Bar-Maor JA; Nissan S
    Isr J Med Sci; 1973 Jan; 9(1):12-8. PubMed ID: 4541818
    [No Abstract]   [Full Text] [Related]  

  • 22. [Abnormal TSH, PRL and GH response to TSH releasing hormone in patients with severe liver cirrhosis (proceedings) (author's transl)].
    Schilienger JL; Jacques C; Demangeat C; Sapin R; Imler M
    Ann Endocrinol (Paris); 1978; 39(3):245-7. PubMed ID: 102237
    [No Abstract]   [Full Text] [Related]  

  • 23. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis.
    Moriya K; Kojima H; Matsumura M; Sakurai S; Imazu H; Uemura M; Honda H; Fukui H
    Hepatogastroenterology; 2003; 50(52):1128-32. PubMed ID: 12845996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reflections on post-portacaval shunt morbidity.
    Warren WD; Fomon JJ
    J Cardiovasc Surg (Torino); 1968; 9(5):453-62. PubMed ID: 5750118
    [No Abstract]   [Full Text] [Related]  

  • 25. Conventional splenorenal shunts. A reconsideration.
    Pliam MB; Adson MA; Foulk WT
    Arch Surg; 1975 May; 110(5):588-93. PubMed ID: 1079450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone release from thyrotrophs and lactotrophs during hypo- and hyperglycemia.
    Röjdmark S; Berg A; Ekström U
    Horm Metab Res; 1989 Sep; 21(9):498-501. PubMed ID: 2511133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate and late effects of porto-caval and spleno-renal shunts on the hepatic function and the neurophysical behavior of patients with hepato-splenic schisotosmiasis.
    Goffi FS; Silva Lde C; Ferrarini E; Juliao AF; Bastos Eda S
    Rev Int Hepatol; 1968; 18(8):933-45. PubMed ID: 5753329
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angiographic control of the permeability of portacaval shunts by selective phlebography].
    Tongio J; Parisot B; Imler M
    J Radiol Electrol Med Nucl; 1973 Nov; 54(11):799-804. PubMed ID: 4799675
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of thyroidal response to thyrotropin (TSH) in decompensated liver cirrhosis.
    Huang TS; Wu HP; Huang LS; Lai MY; Ho SW; Chopra IJ
    Thyroidology; 1989 Dec; 1(3):119-25. PubMed ID: 2484874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective portasystemic shunts: morbidity and survival data.
    Barnes BA; Ackroyd FW; Battit GE; Kantrowitz PA; Schapiro RH; Strole WE; Todd DP; McDermott WV
    Ann Surg; 1971 Jul; 174(1):76-84. PubMed ID: 5314624
    [No Abstract]   [Full Text] [Related]  

  • 31. To what extent is portal hypertension surgery affected by the progress made in splanchnic physiopathology and hepatic biology?
    Staudacher V; Bevilacqua G
    Int Surg; 1972 Jun; 57(6):488-90. PubMed ID: 5038826
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized trial of the selective distal splenorenal shunt.
    Langer B; Rotstein LE; Stone RM; Taylor BR; Patel SC; Blendis LM; Colapinto RF
    Surg Gynecol Obstet; 1980 Jan; 150(1):45-8. PubMed ID: 6965330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term result of 25 splenorenal anastomoses for portal hypertension].
    Saubier EC; Brault JA
    Lyon Med; 1972 Mar; 227(6):517-24. PubMed ID: 4538273
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatofugal portal blood flow in hepatic cirrhosis.
    Foster DN; Herlinger H; Miloszewski KJ; Losowsky MS
    Ann Surg; 1978 Feb; 187(2):179-82. PubMed ID: 629619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liver circulation in patients with cirrhosis before and after anastomosis operations].
    Hoffmeister HE
    Acta Hepatosplenol; 1967; 14(6):358-64. PubMed ID: 5302675
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal-systemic shunt: finally, some good news.
    Reynolds TB
    N Engl J Med; 1976 Nov; 295(20):1131-2. PubMed ID: 980009
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotropin expression in hypophyseal pars tuberalis-specific cells is 3,5,3'-triiodothyronine, thyrotropin-releasing hormone, and pit-1 independent.
    Bockmann J; Böckers TM; Winter C; Wittkowski W; Winterhoff H; Deufel T; Kreutz MR
    Endocrinology; 1997 Mar; 138(3):1019-28. PubMed ID: 9048604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
    Díaz-Fontenla F; Castillo-Pradillo M; Díaz-Gómez A; Ibañez-Samaniego L; Gancedo P; Guzmán-de-Villoria JA; Fernández-García P; Bañares-Cañizares R; García-Martínez R
    World J Gastroenterol; 2017 Jul; 23(28):5246-5252. PubMed ID: 28811719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic contrasts between selective and total portal-systemic decompression.
    Salam AA; Warren WD; LePage JR; Viamonte MR; Hutson D; Zeppa R
    Ann Surg; 1971 May; 173(5):827-44. PubMed ID: 4933303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.